- Home
- VCTR vs SLNO Comparison
VCTR vs SLNO Comparison
Compare VCTR & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCTR
- SLNO
- Stock Information
- Founded
- VCTR 2013
- SLNO 1999
- Country
- VCTR United States
- SLNO United States
- Employees
- VCTR N/A
- SLNO N/A
- Industry
- VCTR Investment Managers
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- VCTR Finance
- SLNO Health Care
- Exchange
- VCTR Nasdaq
- SLNO Nasdaq
- Market Cap
- VCTR 4.6B
- SLNO 3.8B
- IPO Year
- VCTR 2018
- SLNO 2014
- Fundamental
- Price
- VCTR $64.41
- SLNO $67.51
- Analyst Decision
- VCTR Buy
- SLNO Strong Buy
- Analyst Count
- VCTR 9
- SLNO 9
- Target Price
- VCTR $73.11
- SLNO $116.78
- AVG Volume (30 Days)
- VCTR 402.5K
- SLNO 1.4M
- Earning Date
- VCTR 11-06-2025
- SLNO 11-04-2025
- Dividend Yield
- VCTR 3.08%
- SLNO N/A
- EPS Growth
- VCTR 12.49
- SLNO N/A
- EPS
- VCTR 4.00
- SLNO N/A
- Revenue
- VCTR $1,028,813,000.00
- SLNO $32,656,999.00
- Revenue This Year
- VCTR $48.30
- SLNO N/A
- Revenue Next Year
- VCTR $16.30
- SLNO $182.29
- P/E Ratio
- VCTR $16.10
- SLNO N/A
- Revenue Growth
- VCTR 20.90
- SLNO N/A
- 52 Week Low
- VCTR $47.00
- SLNO $41.50
- 52 Week High
- VCTR $73.42
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- VCTR 42.69
- SLNO 54.79
- Support Level
- VCTR $63.07
- SLNO $63.55
- Resistance Level
- VCTR $66.26
- SLNO $67.93
- Average True Range (ATR)
- VCTR 1.59
- SLNO 3.52
- MACD
- VCTR -0.19
- SLNO 0.42
- Stochastic Oscillator
- VCTR 22.22
- SLNO 59.32
About VCTR Victory Capital Holdings Inc.
Victory Capital Holdings Inc is an independent investment management firm. The company operates its business through franchises and solutions platform. It provides centralized distribution, marketing, and operations infrastructure to the company's franchises and solutions platform. The company operates through one business segment that is Investment management services and products to institutional, intermediary, retirement platforms, and individual investors. The franchises and solutions platform manages a variety of investment strategies for its customers. It derives majority of its revenues from asset-based fees from investment management products and services to individuals and institutions.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.